The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses
NCT ID: NCT06282263
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2023-05-25
2023-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the knowledge levels of nurses about suicide according to the pre-programme and control group?
2. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the perception of efficacy levels of nurses regarding suicide according to the pre-programme and control group.
3. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the stigma levels of nurses towards suicide according to the pre-programme and control group.
4. Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test and post-test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
5. Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test-follow-up test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
Participants will participate the Awareness Development Programme on Suicide Prevention for Oncology Nurses. Oncology Nurses are expected to complete the pre-test, post-test and follow-up tests.
Researchers will compare control group to see if effect of "the Awareness Development Programme on Suicide Prevention"
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attitudes and Stigma Towards Suicidal Behavior in Intensive Care and Emergency Service Nurses
NCT06011655
Emotional Awareness and Communication Training Effectiveness in Oncology Nurses
NCT07231913
A Nurse-led Program for Stroke Patients
NCT05242536
Simple Simulation Based Breast Cancer Awareness Training
NCT06528808
Psychoeducation and Well-Being After Breast Cancer
NCT07284030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
"Awareness Development Program on Suicide Prevention for Oncology Nurses" was applied to the nurses in the experimental group.
"Awareness Development Program on Suicide Prevention for Oncology Nurses"
While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows:
Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks.
Control Group
No programme was applied to the control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Awareness Development Program on Suicide Prevention for Oncology Nurses"
While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows:
Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being a nurse working in oncology inpatient clinics (medical oncology, medical oncology, gastroenterology oncology, nephrology oncology, urooncology, gynaecological oncology, haematological oncology inpatient clinics), Bone Marrow Transplantation (BMT) unit, outpatient chemotherapy unit and oncology outpatient clinic,
* To know how to use a smart mobile phone or computer.
Exclusion Criteria
* To care for paediatric oncology patients,
* To have worked in a psychiatric clinic or to have postgraduate education in the field of psychiatric nursing.
* Failure to attend two out of three sessions during the training programme,
* Failure to demonstrate the motor skills to participate in online training
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sevda Ozturk
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevda Ozturk
Research Assistant Sevda Öztürk
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duygu Hiçdurmaz, Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1292
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.